CAI Q1 2021 Earnings — Caris Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena

CAICaris Life Sciences, Inc.

$5B

Q1 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$81M-23.1% YoY

Gross Profit

$39M47.8% margin

Operating Income

$49M60.4% margin

Net Income

$36M44.2% margin

EPS (Diluted)

$2.04

QoQ Revenue Growth

+25.6%

Cash Flow

Operating Cash Flow

$76M

Free Cash Flow

-$96M

Stock-Based Comp.

$540,000

Balance Sheet

Total Assets

$2.7B

Total Liabilities

$2.0B

Stockholders' Equity

$726M

Cash & Equivalents

$48M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$81M	$105M	-23.1%
Gross Profit	$39M	$51M	-24.6%
Operating Income	$49M	$34M	+45.2%
Net Income	$36M	-$1M	+2787.2%